In The News

Prime Therapeutics Buys Magellan Rx for $1.35B

Twins Cities Business
Share on:

Steven W. Meyer, Timothy J. Scallen, Christopher M. Scotti and JT Schuweiler were featured in the Twin Cities Business article, "Prime Therapeutics Buys Magellan Rx for $1.35B." View the full article.